The key challenge associated with the global extensive stage small cell lung cancer market is the lack of potentially effective treatment that can significantly improve the overall survival of extensive stage small cell lung cancer patienst. Chemotherapy induced toxic effects, lack of effective diagnostic tools that can diagnose help in locating the disease substantially early so that effective treatment can be devised.
Read More